The Clinical Operations Team at QED Therapeutics oversees the planning, execution, and management of clinical trials for precision medicines targeting FGFR-driven disorders. They ensure compliance with regulatory requirements, manage timelines and budgets, and coordinate with cross-functional teams to advance infigratinib through clinical development stages, including its evaluation for achondroplasia and other FGFR-driven tumor types and rare disorders.
View all